Phosphorylation Modulates Survivin Function in Behcet’s Disease
Phosphorylation Modulates Survivin Function in Behcet’s Disease
نویسندگان: علیرضا خبازی اسکویی , ناصر صمدی , خلیل انصارین , یاسمین پهلوان
کلمات کلیدی: Autoimmunity, Apoptosis, Lymphocytes, Inhibition of apoptosis proteins (IAPs), Behcet’s disease
نشریه: 55018 , 2 , 10 , 2020
| نویسنده ثبت کننده مقاله |
علیرضا خبازی اسکویی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
بیماری های بافت همبند |
| کد مقاله |
71184 |
| عنوان فارسی مقاله |
Phosphorylation Modulates Survivin Function in Behcet’s Disease |
| عنوان لاتین مقاله |
Phosphorylation Modulates Survivin Function in Behcet’s Disease |
| ناشر |
4 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Purpose: Survivin is critical for proliferation, maturation, homeostasis and differentiation of
effector and memory lymphocytes. In this study the baculoviral inhibitors of apoptosis proteins
(IAPs) repeat containing 5 (BIRC5) mRNA, survivin, and phosphorylated survivin expression were
evaluated in peripheral blood mononuclear cells (PBMCs), and plasma of patients with Behcet’s
disease (BD).
Methods: In this study, 26 Iranian Azari patients diagnosed with BD and 30 healthy controls were
recruited. Total RNA was extracted from PBMCs. The expression level of survivin was measured
by quantitative real-time polymerase chain reaction (PCR). Survivin plasma levels were measured
using survivin Enzyme-linked immunosorbent assays. Also, western blotting analysis was performed
to measure phosphorylated-survivin and survivin levels in PBMCs and plasma of patients with BD.
Results: In a pilot study, we showed that BIRC5 gene expression increased in BD patients compared
with healthy controls (P<0.05). Western blotting analysis indicated that there was an increase in
phosphorylated survivin expression in PBMCs of BD patients. Our data from western blot analysis
showed survivin level in plasma samples of BD patients was similar to healthy controls. No
significant differences were observed between plasma survivin levels in the BD patients compared
with control group (P>0.05). The expression of phosphorylated survivin at Thr34 in PBMCs of BD
patients with active disease was increased. Plasma phosphorylated survivin levels in having BD
patients were also downregulated compared to healthy individuals.
Conclusion: Analysis of PBMCs indicated increasing expression level of phosphorylated survivin
in PBMCs of BD patients. There was also a downregulation in phosphorylated survivin levels in
plasma of BD patients. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| ee.pdf | 1398/11/30 | 509103 | دانلود |